MPO and diabetic retinopathy: Interestingly, diabetic rats which received MPO at all doses used in this study showed the reduction of aldose reductase activity and the expression of both p38MAPK and ERK1/2 in rat lens together with the improved both diabetic cataract and diabetic retinopathy.